CD8A and neoplasm: As shown in Fig. 6d, tumor-infiltrating Treg cells that had been blocked with anti-PD-1 antibody, were significantly impaired in their ability to suppress the proliferation of CD8+ T cells and IFN-γ production as compared to isotype antibody-treated tumor-infiltrating Treg cells.